Patrick J Mcenany is Director of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 4.48 Million shares of CPRX, which is worth approximately $96.9 Million. The most recent transaction as insider was on Dec 09, 2024, when has been sold 3,533 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.48M
0.08% 3M change
8.8% 12M change
Total Value Held $96.9 Million

PATRICK J MCENANY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 09 2024
BUY
Exercise of conversion of derivative security
-
3,533 Added 0.08%
4,481,702 Common Stock, par valu...
Nov 20 2024
SELL
Open market or private sale
$1,543,525 $21.29 p/Share
72,500 Reduced 1.59%
4,478,169 Common Stock, par valu...
Nov 20 2024
BUY
Exercise of conversion of derivative security
$256,650 $3.54 p/Share
72,500 Added 1.57%
4,550,669 Common Stock, par valu...
Nov 19 2024
SELL
Open market or private sale
$2,083,930 $21.19 p/Share
98,345 Reduced 2.15%
4,478,169 Common Stock, par valu...
Nov 19 2024
BUY
Exercise of conversion of derivative security
$348,141 $3.54 p/Share
98,345 Added 2.1%
4,576,514 Common Stock, par valu...
Nov 14 2024
SELL
Open market or private sale
$971,246 $21.75 p/Share
44,655 Reduced 0.99%
4,478,169 Common Stock, par valu...
Nov 14 2024
BUY
Exercise of conversion of derivative security
$158,078 $3.54 p/Share
44,655 Added 0.98%
4,522,824 Common Stock, par valu...
Nov 13 2024
SELL
Open market or private sale
$2,125,650 $22.98 p/Share
92,500 Reduced 2.02%
4,478,169 Common Stock, par valu...
Nov 13 2024
BUY
Exercise of conversion of derivative security
$327,450 $3.54 p/Share
92,500 Added 1.98%
4,570,669 Common Stock, par valu...
Nov 12 2024
SELL
Open market or private sale
$6,107,220 $23.31 p/Share
262,000 Reduced 5.53%
4,478,169 Common Stock, par valu...
Nov 12 2024
BUY
Exercise of conversion of derivative security
$990,360 $3.78 p/Share
262,000 Added 5.31%
4,670,169 Common Stock, par valu...
Nov 11 2024
SELL
Open market or private sale
$5,416,500 $23.55 p/Share
230,000 Reduced 4.89%
4,478,169 Common Stock, par valu...
Nov 11 2024
BUY
Exercise of conversion of derivative security
$922,300 $4.01 p/Share
230,000 Added 4.66%
4,708,169 Common Stock, par valu...
Aug 22 2024
SELL
Bona fide gift
-
5,100 Reduced 0.11%
4,478,169 Common Stock, par valu...
Aug 15 2024
SELL
Bona fide gift
-
45,000 Reduced 0.99%
4,483,269 Common Stock, par valu...
Jan 30 2024
BUY
Exercise of conversion of derivative security
-
143,000 Added 3.06%
4,528,256 Common Stock, par valu...
Jan 02 2024
BUY
Exercise of conversion of derivative security
$282,500 $1.13 p/Share
250,000 Added 5.39%
4,385,256 Common Stock, par valu...
Dec 27 2023
SELL
Payment of exercise price or tax liability
-
10,362 Reduced 0.25%
4,135,256 Common Stock, par valu...
Dec 27 2023
BUY
Exercise of conversion of derivative security
-
26,333 Added 0.63%
4,145,618 Common Stock, par valu...
May 16 2023
BUY
Exercise of conversion of derivative security
$137,340 $0.79 p/Share
173,849 Added 4.05%
4,119,285 Common Stock, par valu...
May 15 2023
SELL
Open market or private sale
$345,977 $13.23 p/Share
26,151 Reduced 0.66%
3,945,436 Common Stock, par valu...
May 15 2023
BUY
Exercise of conversion of derivative security
$20,659 $0.79 p/Share
26,151 Added 0.65%
3,971,587 Common Stock, par valu...
Feb 15 2023
SELL
Payment of exercise price or tax liability
-
14,204 Reduced 0.36%
3,945,436 Common Stock, par valu...
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
58,333 Added 1.45%
3,959,640 Common Stock, par valu...
Dec 29 2022
SELL
Bona fide gift
-
10,000 Reduced 0.26%
3,901,307 Common Stock, par valu...
PJM

Patrick J Mcenany

Director
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX